Glucagon (22-29)
Glucagon (22-29) is partial agonist of Glucagon (19–29) . Glucagon specifically inhibits the Ca2+ pump in liver plasma membranes independently of adenylate cyclase activation[1][2].
Product Specifications
CAS Number
32204-93-6
UNSPSC
12352209
Target
GCGR
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/glucagon-22-29.html
Purity
99.69
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CC(C)C)C(N[C@@H](CCSC)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@H](O)C)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC3=CC=CC=C3)N
Molecular Formula
C49H71N11O12S
Molecular Weight
1038.22
References & Citations
[1]Mallat A, et al. A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon. Nature. 1987 Feb 12-18;325 (6105) :620-2.|[2]Pavoine C, et al. Miniglucagon [glucagon- (19-29) ] is a component of the positive inotropic effect of glucagon. Am J Physiol. 1991 May;260 (5 Pt 1) :C993-9.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940952-500 1x 500 µL
Human IgG Immunoglobulin (B33/20), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
